Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan... Show more
Aflac's third-quarter report is a key checkpoint for one of the largest supplemental insurers in the United States and Japan. The company generates a substantial share of its earnings in Japan, which makes currency movements a recurring swing factor in dollar-reported results. Heading into this release, management has emphasized Japan's resilient margins and a more cautious outlook for U.S. net earned premium growth. For investors, the print offers a read on underwriting trends, expense discipline, and whether capital returns remain well supported. A softer yen and elevated benefit-ratio volatility in the U.S. have kept sentiment measured, making this report a useful gauge of the company's earnings durability.
Analysts expect Aflac to report adjusted EPS of approximately $1.79 for the third quarter of 2026, alongside revenue of around $4.11 billion. On the surface, the EPS figure would represent a decline of roughly 28% from the $2.49 reported a year earlier. However, that prior-year result included a one-time net benefit of $0.76 per share from the company's annual actuarial assumption update, a reserve remeasurement gain of about $580 million. Adjusting for that item, the year-ago comparison normalizes to roughly $1.73 per share, meaning current consensus implies modest underlying growth rather than a collapse.
The comparison also carries a foreign-exchange (FX) headwind, as a weakening yen reduces the dollar value of Japan-based profits. Excluding currency effects, adjusted EPS grew slightly in the first half of the year. Key metrics to watch include the Japan benefit ratio, the U.S. pre-tax margin, and whether management reaffirms its full-year guidance for U.S. net earned premium growth, which was recently flagged as likely to come in just below the 3% to 6% target range.
For traders and investors looking to filter the broader market around events like Aflac's quarterly earnings, Tickeron's AI Screener offers an AI-powered stock and exchange-traded fund (ETF) discovery tool. It helps users scan thousands of securities using customizable filters for industry, market capitalization, technical indicators, price patterns, volatility, and performance metrics. The screener surfaces trending stocks, breakout candidates, and trade ideas by combining fundamental data with AI-driven signals, making it faster to narrow a watchlist than manual screening. Explore the AI Screener to see how it can support your own earnings-season research.
Sentiment heading into the report is cautious. Aflac missed consensus EPS estimates in its most recent quarter, posting adjusted EPS of $1.75 against expectations near $1.78, while revenue of about $4.12 billion came in roughly in line. The stock has historically shown modest post-earnings moves, and the shares have traded lower since the August release. Investors appear focused on the sustainability of Japan's improved pre-tax margin and the yen's trajectory, both of which could influence the immediate reaction even if the headline EPS comparison appears weak on a year-over-year basis.
Beyond the November 4 report, investors should watch how Aflac navigates several cross-currents. In Japan, the priority is the benefit ratio and whether management can preserve the recent margin improvement while the yen remains soft. A further decline in the yen would continue to pressure dollar-reported results, even if local-currency profitability holds steady.
In the United States, the focus shifts to net earned premium growth and claims volatility. Management has signaled that 2026 growth may land just below its 3% to 6% range, while the U.S. pre-tax margin has moderated amid a higher benefit ratio. Persistency rates in both segments remain an important indicator of customer retention and long-term revenue stability.
Capital allocation also remains central to the story. Aflac has paired steady dividend increases with substantial buybacks, and any update on the pace of repurchases or the reinsurance strategy will be closely read. Finally, the company's annual actuarial assumption review, typically reflected in third-quarter results, can create headline noise, so investors will likely separate one-time reserve adjustments from underlying operating trends when evaluating the quarter.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a provider of supplemental life and health insurance services
Industry LifeHealthInsurance